免疫学的治療薬の世界市場規模・現状・予測2021年-2027年

QYResearchが発行した調査報告書(QY21JNE3800)
◆英語タイトル:Global Immunotherapeutic Drugs Market Size, Status and Forecast 2021-2027
◆商品コード:QY21JNE3800
◆発行会社(リサーチ会社):QYResearch
◆発行日:2021年6月(※2024年版があります。お問い合わせください。)
◆ページ数:108
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医薬品
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査資料では、免疫学的治療薬の世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(モノクローナル抗体、ワクチン、チェックポイント阻害剤、インターフェロン)、用途別市場規模(病院、診療所、その他)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・免疫学的治療薬の市場動向
・企業の競争状況、市場シェア
・免疫学的治療薬の種類別市場規模(モノクローナル抗体、ワクチン、チェックポイント阻害剤、インターフェロン)
・免疫学的治療薬の用途別市場規模(病院、診療所、その他)
・免疫学的治療薬の北米市場規模2016-2027(アメリカ、カナダ)
・免疫学的治療薬の欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・免疫学的治療薬のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・免疫学的治療薬の中南米市場規模2016-2027(メキシコ、ブラジル)
・免疫学的治療薬の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(Roche、Merck、Novartis、Johnson & Johnson、GlaxoSmithKline、AbbVie、ELI Lilly、Amgen、AstraZeneca、Bristol-Mysers Squibb)
・結論
【レポートの概要】

Immunotherapy is a cancer treatment that enhances the body’s natural defenses against cancer-fighting tissues.In this treatment, substances made in the body or laboratory are used to improve or restore immune system function.The drugs used in this treatment are called immunotherapeutics.Immunotherapy drugs are designed to warn the immune system about mutated cells, so it can easily find and destroy them.

Market Analysis and Insights: Global Immunotherapeutic Drugs Market
The global Immunotherapeutic Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Immunotherapeutic Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Immunotherapeutic Drugs market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Immunotherapeutic Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Immunotherapeutic Drugs market.

Global Immunotherapeutic Drugs Scope and Market Size
Immunotherapeutic Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Immunotherapeutic Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Monoclonal Antibody
Vaccines
Checkpoint Inhibitor
Interferon

Segment by Application
Hospitals
Clinics
Other

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Roche
Merck
Novartis
Johnson & Johnson
GlaxoSmithKline
AbbVie
ELI Lilly
Amgen
AstraZeneca
Bristol-Mysers Squibb

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Immunotherapeutic Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Monoclonal Antibody
1.2.3 Vaccines
1.2.4 Checkpoint Inhibitor
1.2.5 Interferon
1.3 Market by Application
1.3.1 Global Immunotherapeutic Drugs Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Immunotherapeutic Drugs Market Perspective (2016-2027)
2.2 Immunotherapeutic Drugs Growth Trends by Regions
2.2.1 Immunotherapeutic Drugs Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Immunotherapeutic Drugs Historic Market Share by Regions (2016-2021)
2.2.3 Immunotherapeutic Drugs Forecasted Market Size by Regions (2022-2027)
2.3 Immunotherapeutic Drugs Industry Dynamic
2.3.1 Immunotherapeutic Drugs Market Trends
2.3.2 Immunotherapeutic Drugs Market Drivers
2.3.3 Immunotherapeutic Drugs Market Challenges
2.3.4 Immunotherapeutic Drugs Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Immunotherapeutic Drugs Players by Revenue
3.1.1 Global Top Immunotherapeutic Drugs Players by Revenue (2016-2021)
3.1.2 Global Immunotherapeutic Drugs Revenue Market Share by Players (2016-2021)
3.2 Global Immunotherapeutic Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Immunotherapeutic Drugs Revenue
3.4 Global Immunotherapeutic Drugs Market Concentration Ratio
3.4.1 Global Immunotherapeutic Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Immunotherapeutic Drugs Revenue in 2020
3.5 Immunotherapeutic Drugs Key Players Head office and Area Served
3.6 Key Players Immunotherapeutic Drugs Product Solution and Service
3.7 Date of Enter into Immunotherapeutic Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Immunotherapeutic Drugs Breakdown Data by Type
4.1 Global Immunotherapeutic Drugs Historic Market Size by Type (2016-2021)
4.2 Global Immunotherapeutic Drugs Forecasted Market Size by Type (2022-2027)

5 Immunotherapeutic Drugs Breakdown Data by Application
5.1 Global Immunotherapeutic Drugs Historic Market Size by Application (2016-2021)
5.2 Global Immunotherapeutic Drugs Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Immunotherapeutic Drugs Market Size (2016-2027)
6.2 North America Immunotherapeutic Drugs Market Size by Type
6.2.1 North America Immunotherapeutic Drugs Market Size by Type (2016-2021)
6.2.2 North America Immunotherapeutic Drugs Market Size by Type (2022-2027)
6.2.3 North America Immunotherapeutic Drugs Market Size by Type (2016-2027)
6.3 North America Immunotherapeutic Drugs Market Size by Application
6.3.1 North America Immunotherapeutic Drugs Market Size by Application (2016-2021)
6.3.2 North America Immunotherapeutic Drugs Market Size by Application (2022-2027)
6.3.3 North America Immunotherapeutic Drugs Market Size by Application (2016-2027)
6.4 North America Immunotherapeutic Drugs Market Size by Country
6.4.1 North America Immunotherapeutic Drugs Market Size by Country (2016-2021)
6.4.2 North America Immunotherapeutic Drugs Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Immunotherapeutic Drugs Market Size (2016-2027)
7.2 Europe Immunotherapeutic Drugs Market Size by Type
7.2.1 Europe Immunotherapeutic Drugs Market Size by Type (2016-2021)
7.2.2 Europe Immunotherapeutic Drugs Market Size by Type (2022-2027)
7.2.3 Europe Immunotherapeutic Drugs Market Size by Type (2016-2027)
7.3 Europe Immunotherapeutic Drugs Market Size by Application
7.3.1 Europe Immunotherapeutic Drugs Market Size by Application (2016-2021)
7.3.2 Europe Immunotherapeutic Drugs Market Size by Application (2022-2027)
7.3.3 Europe Immunotherapeutic Drugs Market Size by Application (2016-2027)
7.4 Europe Immunotherapeutic Drugs Market Size by Country
7.4.1 Europe Immunotherapeutic Drugs Market Size by Country (2016-2021)
7.4.2 Europe Immunotherapeutic Drugs Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Immunotherapeutic Drugs Market Size (2016-2027)
8.2 Asia-Pacific Immunotherapeutic Drugs Market Size by Type
8.2.1 Asia-Pacific Immunotherapeutic Drugs Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Immunotherapeutic Drugs Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Immunotherapeutic Drugs Market Size by Type (2016-2027)
8.3 Asia-Pacific Immunotherapeutic Drugs Market Size by Application
8.3.1 Asia-Pacific Immunotherapeutic Drugs Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Immunotherapeutic Drugs Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Immunotherapeutic Drugs Market Size by Application (2016-2027)
8.4 Asia-Pacific Immunotherapeutic Drugs Market Size by Region
8.4.1 Asia-Pacific Immunotherapeutic Drugs Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Immunotherapeutic Drugs Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Immunotherapeutic Drugs Market Size (2016-2027)
9.2 Latin America Immunotherapeutic Drugs Market Size by Type
9.2.1 Latin America Immunotherapeutic Drugs Market Size by Type (2016-2021)
9.2.2 Latin America Immunotherapeutic Drugs Market Size by Type (2022-2027)
9.2.3 Latin America Immunotherapeutic Drugs Market Size by Type (2016-2027)
9.3 Latin America Immunotherapeutic Drugs Market Size by Application
9.3.1 Latin America Immunotherapeutic Drugs Market Size by Application (2016-2021)
9.3.2 Latin America Immunotherapeutic Drugs Market Size by Application (2022-2027)
9.3.3 Latin America Immunotherapeutic Drugs Market Size by Application (2016-2027)
9.4 Latin America Immunotherapeutic Drugs Market Size by Country
9.4.1 Latin America Immunotherapeutic Drugs Market Size by Country (2016-2021)
9.4.2 Latin America Immunotherapeutic Drugs Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Immunotherapeutic Drugs Market Size (2016-2027)
10.2 Middle East & Africa Immunotherapeutic Drugs Market Size by Type
10.2.1 Middle East & Africa Immunotherapeutic Drugs Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Immunotherapeutic Drugs Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Immunotherapeutic Drugs Market Size by Type (2016-2027)
10.3 Middle East & Africa Immunotherapeutic Drugs Market Size by Application
10.3.1 Middle East & Africa Immunotherapeutic Drugs Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Immunotherapeutic Drugs Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Immunotherapeutic Drugs Market Size by Application (2016-2027)
10.4 Middle East & Africa Immunotherapeutic Drugs Market Size by Country
10.4.1 Middle East & Africa Immunotherapeutic Drugs Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Immunotherapeutic Drugs Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Roche Business Overview
11.1.3 Roche Immunotherapeutic Drugs Introduction
11.1.4 Roche Revenue in Immunotherapeutic Drugs Business (2016-2021)
11.1.5 Roche Recent Development
11.2 Merck
11.2.1 Merck Company Details
11.2.2 Merck Business Overview
11.2.3 Merck Immunotherapeutic Drugs Introduction
11.2.4 Merck Revenue in Immunotherapeutic Drugs Business (2016-2021)
11.2.5 Merck Recent Development
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis Immunotherapeutic Drugs Introduction
11.3.4 Novartis Revenue in Immunotherapeutic Drugs Business (2016-2021)
11.3.5 Novartis Recent Development
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Details
11.4.2 Johnson & Johnson Business Overview
11.4.3 Johnson & Johnson Immunotherapeutic Drugs Introduction
11.4.4 Johnson & Johnson Revenue in Immunotherapeutic Drugs Business (2016-2021)
11.4.5 Johnson & Johnson Recent Development
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Company Details
11.5.2 GlaxoSmithKline Business Overview
11.5.3 GlaxoSmithKline Immunotherapeutic Drugs Introduction
11.5.4 GlaxoSmithKline Revenue in Immunotherapeutic Drugs Business (2016-2021)
11.5.5 GlaxoSmithKline Recent Development
11.6 AbbVie
11.6.1 AbbVie Company Details
11.6.2 AbbVie Business Overview
11.6.3 AbbVie Immunotherapeutic Drugs Introduction
11.6.4 AbbVie Revenue in Immunotherapeutic Drugs Business (2016-2021)
11.6.5 AbbVie Recent Development
11.7 ELI Lilly
11.7.1 ELI Lilly Company Details
11.7.2 ELI Lilly Business Overview
11.7.3 ELI Lilly Immunotherapeutic Drugs Introduction
11.7.4 ELI Lilly Revenue in Immunotherapeutic Drugs Business (2016-2021)
11.7.5 ELI Lilly Recent Development
11.8 Amgen
11.8.1 Amgen Company Details
11.8.2 Amgen Business Overview
11.8.3 Amgen Immunotherapeutic Drugs Introduction
11.8.4 Amgen Revenue in Immunotherapeutic Drugs Business (2016-2021)
11.8.5 Amgen Recent Development
11.9 AstraZeneca
11.9.1 AstraZeneca Company Details
11.9.2 AstraZeneca Business Overview
11.9.3 AstraZeneca Immunotherapeutic Drugs Introduction
11.9.4 AstraZeneca Revenue in Immunotherapeutic Drugs Business (2016-2021)
11.9.5 AstraZeneca Recent Development
11.10 Bristol-Mysers Squibb
11.10.1 Bristol-Mysers Squibb Company Details
11.10.2 Bristol-Mysers Squibb Business Overview
11.10.3 Bristol-Mysers Squibb Immunotherapeutic Drugs Introduction
11.10.4 Bristol-Mysers Squibb Revenue in Immunotherapeutic Drugs Business (2016-2021)
11.10.5 Bristol-Mysers Squibb Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

...

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 免疫学的治療薬の世界市場規模・現状・予測2021年-2027年(Global Immunotherapeutic Drugs Market Size, Status and Forecast 2021-2027)]についてメールでお問い合わせはこちらでお願いします。